相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lysophospholipid Mediators in Health and Disease
Kuniyuki Kano et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2022)
Influence of the autotaxin-lysophosphatidic acid axis on cellular function and cytokine expression in different breast cancer cell lines
Theresa Hauck et al.
SCIENTIFIC REPORTS (2022)
Autotaxin in ascites promotes peritoneal dissemination in pancreatic cancer
Naruomi Jinno et al.
CANCER SCIENCE (2021)
NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis
Anna Malczewska et al.
ENDOCRINE CONNECTIONS (2021)
Evaluation of serum ATX and LPA as potential diagnostic biomarkers in patients with pancreatic cancer
Jiang Chen et al.
BMC GASTROENTEROLOGY (2021)
Design and Development of Autotaxin Inhibitors
Yi Jia et al.
PHARMACEUTICALS (2021)
Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies
Luiz Henrique Medeiros Geraldo et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer
Xiaoyun Tang et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Autotaxin and Breast Cancer: Towards Overcoming Treatment Barriers and Sequelae
Matthew G. K. Benesch et al.
CANCERS (2020)
Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated Tumorigenesis
You Feng et al.
CANCER RESEARCH (2020)
ONO-8430506: A Novel Autotaxin Inhibitor That Enhances the Antitumor Effect of Paclitaxel in a Breast Cancer Model
Yuzo Iwaki et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Rb and p53 Execute Distinct Roles in the Development of Pancreatic Neuroendocrine Tumors
Yuki Yamauchi et al.
CANCER RESEARCH (2020)
Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study
Toshihiko Masui et al.
BMC CANCER (2020)
Assessment of NETest Clinical Utility in a US Registry-Based Study
Eric Liu et al.
ONCOLOGIST (2019)
Serum ATX as a novel biomarker for breast cancer
Yingbo Shao et al.
MEDICINE (2019)
A Stromal Lysolipid-Autotaxin Signaling Axis Promotes Pancreatic Tumor Progression
Francesca R. Auciello et al.
CANCER DISCOVERY (2019)
Evaluation and Management of Neuroendocrine Tumors of the Pancreas
Aaron T. Scott et al.
SURGICAL CLINICS OF NORTH AMERICA (2019)
Lysophosphatidic Acid and Autotaxin-associated Effects on the Initiation and Progression of Colorectal Cancer
C. Chris Yun
CANCERS (2019)
Expression of proteins related to autotaxin-lysophosphatidate signaling in thyroid tumors
Eunah Shin et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Role of autotaxin in cancer stem cells
Dongjun Lee et al.
CANCER AND METASTASIS REVIEWS (2018)
Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial
Toby M. Maher et al.
LANCET RESPIRATORY MEDICINE (2018)
The NETest The Clinical Utility of Multigene Blood Analysis - in the Diagnosis and Management of Neuroendocrine Tumors
Irvin M. Modlin et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2018)
NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes Progressive
Marianne Pavel et al.
NEUROENDOCRINOLOGY (2017)
Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis
Nicolas Desroy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development
Silvia Anahi Valdes-Rives et al.
MEDIATORS OF INFLAMMATION (2017)
The critical role and potential target of the autotaxin/lysophosphatidate axis in pancreatic cancer
Ming Quan et al.
TUMOR BIOLOGY (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas
Laura H. Tang et al.
CLINICAL CANCER RESEARCH (2016)
Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression
Lorenzo Federico et al.
JOURNAL OF LIPID RESEARCH (2016)
Blood and tissue neuroendocrine tumor gene cluster analysis correlate, define hallmarks and predict disease status
Mark Kidd et al.
ENDOCRINE-RELATED CANCER (2015)
A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection
Irvin M. Modlin et al.
ENDOCRINE-RELATED CANCER (2014)
Inhibition of autotaxin delays breast tumor growth and lung metastasis in mice
Matthew G. K. Benesch et al.
FASEB JOURNAL (2014)
Neuroendocrine Tumor Biomarkers: Current Status and Perspectives
Irvin M. Modlin et al.
NEUROENDOCRINOLOGY (2014)
Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors
Shinichi Yachida et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Autotaxin and LPA receptor signaling in cancer
Anna J. S. Houben et al.
CANCER AND METASTASIS REVIEWS (2011)
Specific increase in serum autotaxin activity in patients with pancreatic cancer
Yousuke Nakai et al.
CLINICAL BIOCHEMISTRY (2011)
Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation
Harald M. H. G. Albers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Reduced expression of autotaxin predicts survival in uveal melanoma
Arun D. Singh et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2007)
分享论文
